tiprankstipranks
Prothena selloff ‘misplaced,’ brings buying opportunity, says H.C. Wainwright
PremiumThe FlyProthena selloff ‘misplaced,’ brings buying opportunity, says H.C. Wainwright
2M ago
Prothena’s downside move may be excessive, says RBC Capital
Premium
The Fly
Prothena’s downside move may be excessive, says RBC Capital
2M ago
Oppenheimer says Prothena’s Garren left for ‘amazing opportunity’
Premium
The Fly
Oppenheimer says Prothena’s Garren left for ‘amazing opportunity’
2M ago
Prothena price target lowered to $62 from $66 at Oppenheimer
PremiumThe FlyProthena price target lowered to $62 from $66 at Oppenheimer
3M ago
3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24)
Premium
Market News
3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24)
3M ago
Prothena price target lowered to $24 from $28 at RBC Capital
Premium
The Fly
Prothena price target lowered to $24 from $28 at RBC Capital
3M ago
Prothena announces Bristol Myers Squibb obtained exclusive PRX019 license
PremiumThe FlyProthena announces Bristol Myers Squibb obtained exclusive PRX019 license
6M ago
Prothena Shareholders Approve Incentives and Governance Measures
Premium
Company Announcements
Prothena Shareholders Approve Incentives and Governance Measures
6M ago
Prothena price target lowered to $83 from $85 at JMP Securities
Premium
The Fly
Prothena price target lowered to $83 from $85 at JMP Securities
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100